Company / EPS (Diluted)
Cytek Biosciences, Inc. EPS (Diluted) History
FY2020-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.09
FY2023
5-year range
-$0.09 / $0.10
FY2020-FY2023
Trend
-190.0%
vs FY2022
Sector context
#97 of 159
Health Care
What the data says
At $-0.09, Cytek Biosciences, Inc.'s eps (diluted) ranks #97 of 159 in the Health Care sector. Declined from $0.10 to $-0.09 over the past 2 years.
Based on SEC 10-K filings.
-0.09 in FY2023.
Declined from $0.10 to $-0.09 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#97 of 159 in Health CareTop 61% of 159This company -$0.09 Sector average $1.56
▼
-105.8% below sector average
Key checks
Key Insights
- In FY2023, eps (diluted) decreased 190.0% year-over-year.
- Ranks #97 out of 159 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | -$0.09 | -190.0% |
| FY2022 | $0.10 | +0.0% |
| FY2021 | $0.10 | +0.0% |
| FY2020 | $0.10 | - |
As of FY2023 · SEC 10-K · Updated Jul 2, 2026